It is a solid growth company but it has been unfairly undervalued due to bad sentiment towards BKL from Jan-June. Now BKL is on its way back in 2017 FY there is no reason why VIT can't do the same at some point. VIT worth $2 plus with its current business and earnings. It also got huge potential to expand to other high margin business such as skin care. If they can achieve half of the trilogy success which VIT had worked with before, it will attract a massive re-rating again!!
Ann: Investor Presentation-VIT.AX, page-47
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
